Abstract

The tumorvirus human T-cell lymphotropic virus type 1 (HTLV-1), a member of the delta-retrovirus family, is transmitted via cell-containing body fluids such as blood products, semen, and breast milk. In vivo, HTLV-1 preferentially infects CD4+ T-cells, and to a lesser extent, CD8+ T-cells, dendritic cells, and monocytes. Efficient infection of CD4+ T-cells requires cell-cell contacts while cell-free virus transmission is inefficient. Two types of cell-cell contacts have been described to be critical for HTLV-1 transmission, tight junctions and cellular conduits. Further, two non-exclusive mechanisms of virus transmission at cell-cell contacts have been proposed: (1) polarized budding of HTLV-1 into synaptic clefts; and (2) cell surface transfer of viral biofilms at virological synapses. In contrast to CD4+ T-cells, dendritic cells can be infected cell-free and, to a greater extent, via viral biofilms in vitro. Cell-to-cell transmission of HTLV-1 requires a coordinated action of steps in the virus infectious cycle with events in the cell-cell adhesion process; therefore, virus propagation from cell-to-cell depends on specific interactions between cellular and viral proteins. Here, we review the molecular mechanisms of HTLV-1 transmission with a focus on the HTLV-1-encoded proteins Tax and p8, their impact on host cell factors mediating cell-cell contacts, cytoskeletal remodeling, and thus, virus propagation.

Highlights

  • Human T-cell lymphotropic virus type 1 (HTLV-1), a delta-retrovirus, is the causative agent of a severe and fatal lymphoproliferative disorder of CD4+ T-cells, adult T-cell leukemia/lymphoma (ATL), and of a neurodegenerative, inflammatory disease, HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) [1,2,3,4,5]

  • After uncoating and reverse transcription, HTLV-1 integrates into the host cell genome and is predominantly maintained in its provirus form (9.1 kb), which is flanked by long terminal repeats (LTR) in both the 5' and 3' region carrying the viral promoter

  • The cell tip of the conduit towardstransfer the targetof cell via a “mini. It betweenHTLV-1 conduitbuds andfrom target suggests protected between and is in contrast to is not known whether p8 and LFA-1 cluster at the tip of the conduit, or only at the surface of the transmission of the related retroviruses human immunodeficiency virus (HIV) and murine leukemia virus (MLV), where isolated viral particles were shown to infected cell

Read more

Summary

Introduction

Human T-cell lymphotropic virus type 1 (HTLV-1), a delta-retrovirus, is the causative agent of a severe and fatal lymphoproliferative disorder of CD4+ T-cells, adult T-cell leukemia/lymphoma (ATL), and of a neurodegenerative, inflammatory disease, HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) [1,2,3,4,5]. After uncoating and reverse transcription, HTLV-1 integrates into the host cell genome and is predominantly maintained in its provirus form (9.1 kb), which is flanked by long terminal repeats (LTR) in both the 5' and 3' region carrying the viral promoter (reviewed by [19]). The accessory proteins p12/p8, p13, and p30 are important for viral infectivity and persistence in vivo, but not for virus replication in vitro [21]. An important role in HTLV-1-induced cellular transformation has been attributed to the viral oncoprotein Tax, which is sufficient to immortalize T-cells in vitro [19]. Important roles for promoting viral replication and cellular proliferation have been attributed to the HBZ protein and to HBZ RNA. We focus on the HTLV-1-encoded proteins Tax and p8, their impact on host factors mediating cell-cell contacts, cytoskeletal remodeling, and virus transmission

Target Cells of HTLV-1 in Vivo
Routes of Viral Transmission in Vivo
Transmission at Tight Cell-Cell Contacts
Transmission of Viral Biofilms at the VS
Transmission via Cellular Conduits
Viral Proteins Enhancing HTLV-1 Transmission
Host Factors Involved in HTLV-1 Transmission
Cell Surface Receptors and Cell-Cell Contacts
Components and Regulators of the Cytoskeleton
Signaling Pathways
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call